Breaking News Instant updates and real-time market news.

NFLX

Netflix

$257.95

8.48 (3.40%)

, AMZN

Amazon.com

$1,386.23

46.63 (3.48%)

12:32
02/13/18
02/13
12:32
02/13/18
12:32

Cuban says Netflix and Amazon are two largest holdings

Mark Cuban is speaking on CNBC.

NFLX

Netflix

$257.95

8.48 (3.40%)

AMZN

Amazon.com

$1,386.23

46.63 (3.48%)

  • 23

    Feb

  • 18

    Mar

  • 20

    Mar

NFLX Netflix
$257.95

8.48 (3.40%)

01/24/18
BTIG
01/24/18
NO CHANGE
Target $330
BTIG
Buy
Netflix price target raised to $330 from $225 at BTIG
BTIG analyst Richard Greenfield raised his price target on Netflix to $330 after its above-forecast subscription additions. The analyst believes that while it took the company 10 years to achieve 100M subscribers, it could take only 2 1/2 years to add another 100M, creating a "virtuous circle of more subscribers at higher prices enabling Netflix to invest in more content that is attracting more subscribers who are willing to pay more per month". Greenfield keeps his Buy rating on Netflix.
01/24/18
ARGS
01/24/18
NO CHANGE
ARGS
Hold
Netflix valuation 'significantly above peers', says Argus
Argus analyst Joseph Bonner keeps his Hold rating on Netflix while raising his FY18 EPS estimated to $2.73 from $2.01 after the company's latest earnings report. Bonner warns however that while Netflix subscription count is benefiting from a "secular growth of internet-delivered on-demand video", the company is also taking on more debt and burning through cash while attracting a host of competitors that include its own suppliers - Time Warner (TWX), Disney (DIS), and HBO - along with "deep-pocketed" rivals AT&T (T), Amazon (AMZN), Facebook (FB), and Google (GOOGL). The analyst adds that the valuation metrics on Netflix are also significantly higher than peers at a trailing EV/EBITDA multiple of 124-times - well above both the peer average of 29-times and Amazon's 50-times.
01/29/18
MKMP
01/29/18
NO CHANGE
Target $320
MKMP
Buy
Netflix price target raised to $320 from $245 at MKM Partners
MKM Partners analyst Rob Sanderson raised his price target on Netflix to $320 and kept his Buy rating after last week's "blow-out" results and earnings. The analyst contends that the peak for subscription additions is still a few years away and believes that investors underestimate the global appeal for the company's content, the expanding content investment driving higher consumer demand, and the internet-driven scale of content investment.
02/09/18
RHCO
02/09/18
DOWNGRADE
Target $31
RHCO
Hold
Lionsgate downgraded to Hold from Buy at SunTrust
SunTrust analyst Matthew Thornton downgraded Lionsgate (LGF.B) to Hold from Buy and lowered his price target to $31 from $36 after the company lowered its 3-year OIBDA growth outlook to 7.8% from about 13% amid accelerated investment in Starz and international divisions. Thornton notes that while the added spending is justifiable, the multiple needs to reflect the updated model as confidence in more back-end loaded guidance has been shaken. Among his areas of concern, Thornton also lists "accelerating mix shift to originals from licensed content", impact of Netflix (NFLX) on box office and competition for projects, and impact on Starz from bundling deals such as T-Mobile (TMUS) with Netflix and AT&T (T) with HBO.
AMZN Amazon.com
$1,386.23

46.63 (3.48%)

02/13/18
DADA
02/13/18
NO CHANGE
Target $1800
DADA
Buy
Amazon.com investors should take advantage of pullback, says DA Davidson
DA Davidson analyst Tom Forte keeps his Buy rating and $1,800 on Amazon.com but says that investors should take advantage of the latest pullback to add to their positions. In addition to valuation, Forte cites the press reports on the latest hiring of Jennifer Salke as the new head of Amazon Studios, thereby filling "an important void after a potential period of disruption" and bringing one of its most significant areas of investment - proprietary content - back on track. The analyst notes that among Salke's prior accomplishments as the President of NBC Entertainment were hit shows such as "This Is Us", "Glee", "Modern Family", and "Prison Break".
02/13/18
WELS
02/13/18
NO CHANGE
WELS
AmerisourceBergen acquisition by Walgreens makes sense, says Wells Fargo
Commenting on The Wall Street Journal report saying Walgreens (WBA) has approached AmerisourceBergen (ABC) in a takeover attempt and the companies remain early in their discussions, Wells Fargo analyst Peter Costa tells investors he believes the acquisition makes sense given the already existing long-term partnership and limited ability to merge laterally. Further, the analyst believes a potential combination could help lower costs and wring out synergies in the U.S. drug distribution channel, and better position Walgreens in the face of increasing competitive threat from a possible Amazon (AMZN) entry. However, a merger might risk alienating AmerisourceBergen's retail pharmacy customers that compete with Walgreens' pharmacies, he contends.
02/13/18
MACQ
02/13/18
NO CHANGE
Target $1750
MACQ
Outperform
Amazon's Twitch aggregate viewership continues to rise, says Macquarie
Macquarie analyst Benjamin Schachter says Amazon's (AMZN) Twitch aggregate viewership continues to rise, and Twitch is now bigger than CNN (TWX). While eSports as a whole is becoming a more concrete opportunity, the analyst notes that which games and genres will be the most popular/viewed eSports over time is unclear. Schachter also highlights that the Overwatch League launched to peak views of over 408K and over 10M unique viewers across the opening week, and that display ads on Amazon properties like Twitch are meaningful contributors to Other revenue, which grew 58% to $4.65B in 2017. He reiterates an Outperform rating and $1,750 price target on Amazon's shares.
02/13/18
NEED
02/13/18
NO CHANGE
NEED
Needham a buyer of Medical Technologies product makers on Amazon headlines
After The Wall Street Journal report claiming that Amazon (AMZN) is attempting to become a major hospital supplier, Needham analyst Mike Matson said that he believes the e-commerce giant has typically disrupted middlemen much more than manufacturers. The analyst, who thinks Amazon's model may work for "lower tech" products but is unlikely to work with "higher tech" products, would be a buyer of Medical Technologies product maker stocks if they are down on weakness related to the headline risk represented by Amazon. However, Matson notes that he believe that Cantel Medical (CMD), CONMED (CNMD), Medtronic (MDT), Stryker (SYK) and Teleflex (TFX) generate a portion of their sales from "lower tech" products. Other stocks in MedTech manufacturing include AtriCure (ATRI), Cardiovascular Systems (CSII), Hill-Rom (HRC), K2M Group (KTWO), Mazor Robotics (MZOR), Zimmer Biomet (ZBH), Boston Scientific (BSX), Globus Medical (GMED), NuVasive (NUVA) and Wright Medical (WMGI).

TODAY'S FREE FLY STORIES

WMT

Walmart

$95.22

-9.56 (-9.12%)

12:21
02/20/18
02/20
12:21
02/20/18
12:21
Recommendations
Walmart analyst commentary  »

Walmart e-commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

WMT

Walmart

$95.23

-9.55 (-9.11%)

, HD

Home Depot

$189.64

2.67 (1.43%)

12:17
02/20/18
02/20
12:17
02/20/18
12:17
General news
On The Fly: Top stock stories at midday »

Stocks opened deep in…

WMT

Walmart

$95.23

-9.55 (-9.11%)

HD

Home Depot

$189.64

2.67 (1.43%)

NXPI

NXP Semiconductors

$118.50

1.58 (1.35%)

QCOM

Qualcomm

$64.85

-0.43 (-0.66%)

AVGO

Broadcom

$248.89

-2.94 (-1.17%)

RAD

Rite Aid

$2.21

0.0801 (3.76%)

MDXG

MiMedx

$14.47

-0.96 (-6.22%)

UBNT

Ubiquiti

$74.04

-1.25 (-1.66%)

VYGR

Voyager Therapeutics

$19.36

0.19 (0.99%)

ABBV

AbbVie

$120.79

2.19 (1.85%)

FOGO

Fogo De Chao

$12.55

-0.15 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 14

    Mar

  • 18

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

$NSD

NASDAQ Market Internals

12:17
02/20/18
02/20
12:17
02/20/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
02/20/18
02/20
12:16
02/20/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$14.23

0.105 (0.74%)

12:15
02/20/18
02/20
12:15
02/20/18
12:15
Options
Vale put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFII

Electronics for Imaging

$28.11

0.04 (0.14%)

12:10
02/20/18
02/20
12:10
02/20/18
12:10
Conference/Events
Electronics for Imaging management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 13

    Mar

  • 14

    Mar

BHP

BHP Billiton

$46.89

-1.8 (-3.70%)

12:09
02/20/18
02/20
12:09
02/20/18
12:09
Downgrade
BHP Billiton rating change  »

BHP Billiton downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$41.63

-0.51 (-1.21%)

12:05
02/20/18
02/20
12:05
02/20/18
12:05
Options
Mylan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 13

    Nov

12:05
02/20/18
02/20
12:05
02/20/18
12:05
General news
Euro$ interest rate futures are mostly lower »

Euro$ interest rate…

SYNT

Syntel

$26.87

1.16 (4.51%)

12:03
02/20/18
02/20
12:03
02/20/18
12:03
Conference/Events
Syntel management to meet with Loop Capital »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

HSIC

Henry Schein

$69.52

1.14 (1.67%)

12:00
02/20/18
02/20
12:00
02/20/18
12:00
Downgrade
Henry Schein rating change  »

Henry Schein downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

12:00
02/20/18
02/20
12:00
02/20/18
12:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

GPS

Gap

$32.18

-1.0899 (-3.28%)

11:58
02/20/18
02/20
11:58
02/20/18
11:58
Recommendations
Gap analyst commentary  »

Jefferies remains buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 18

    Mar

HSIC

Henry Schein

$69.52

1.14 (1.67%)

11:55
02/20/18
02/20
11:55
02/20/18
11:55
Downgrade
Henry Schein rating change  »

Henry Schein downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

OZM

Och-Ziff Capital

$2.56

-0.035 (-1.35%)

11:55
02/20/18
02/20
11:55
02/20/18
11:55
Conference/Events
CFA Society of Columbus to hold a luncheon meeting »

Group Luncheon with guest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

DBVT

DBV Technologies

$25.86

-0.29 (-1.11%)

, AIMT

Aimmune

$37.20

-1.04 (-2.72%)

11:54
02/20/18
02/20
11:54
02/20/18
11:54
Recommendations
DBV Technologies, Aimmune analyst commentary  »

DBV Technologies wins…

DBVT

DBV Technologies

$25.86

-0.29 (-1.11%)

AIMT

Aimmune

$37.20

-1.04 (-2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 02

    Mar

  • 11

    Mar

KEYW

KEYW

$7.51

0.01 (0.13%)

11:53
02/20/18
02/20
11:53
02/20/18
11:53
Conference/Events
KEYW management to meet with Maxim »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 15

    Mar

  • 14

    Jun

CMCSA

Comcast

$39.79

-0.29 (-0.72%)

, CMCSK

Comcast

11:51
02/20/18
02/20
11:51
02/20/18
11:51
Hot Stocks
NBC ratings down for PyeongChang Olympics »

Comcast's (CMCSA,…

CMCSA

Comcast

$39.79

-0.29 (-0.72%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 05

    Mar

ATOS

Atossa Genetics

$0.63

-0.0655 (-9.49%)

11:50
02/20/18
02/20
11:50
02/20/18
11:50
Conference/Events
Atossa Genetics management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

V

Visa

$122.66

0.81 (0.66%)

11:50
02/20/18
02/20
11:50
02/20/18
11:50
Options
Defensive spread opened in Visa »

Defensive spread opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 01

    Mar

  • 30

    May

11:50
02/20/18
02/20
11:50
02/20/18
11:50
General news
Treasury's record $96 B 3- and 6-month bill sale saw mixed results »

Treasury's record…

11:45
02/20/18
02/20
11:45
02/20/18
11:45
General news
Treasury Option Action: some call buying in the belly »

Treasury Option Action:…

SNAP

Snap

$19.61

-0.81 (-3.97%)

11:42
02/20/18
02/20
11:42
02/20/18
11:42
Hot Stocks
Snap slides after Citi says sell on redesign concerns »

Shares of Snap (SNAP) are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 07

    Mar

LNDC

Landec

$13.90

0.35 (2.58%)

11:41
02/20/18
02/20
11:41
02/20/18
11:41
Conference/Events
Landec management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Mar

  • 21

    Mar

WFC

Wells Fargo

$60.43

0.48 (0.80%)

11:40
02/20/18
02/20
11:40
02/20/18
11:40
Options
Active trading in Wells Fargo options »

Active trading in Wells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

  • 15

    Mar

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.